United States Biotechnology & Medical Research

Concert Pharmaceuticals Inc (CNCE)

Track

Ticker: CNCE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Concert Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 15 Feb 2023
Value US$2,734,162.77 | Price 65.76 | Shares 86,214 (+4.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-02-16 2023-02-15 PlS Planned sale
Munsie Jeffrey A

Chief Legal Officer

Officer
86,214 +4.6%
65.76
US$2,734,163 		86,214 +4.6% 65.76 US$2,734,163
2023-02-16 2023-02-15 PlS Planned sale
Cassella James V

Chief Development Officer

Officer
83,909 -35.0%
180.22
US$782,052 		83,909 -35.0% 180.22 US$782,052
2023-02-16 2023-02-15 PlS Planned sale
Becker Marc A.

Chief Financial Officer

Officer
9,323 +49.4%
37.82
US$3,692,381 		9,323 +49.4% 37.82 US$3,692,381
2023-02-16 2023-02-15 PlS Planned sale
2.4
Stuart Nancy

Chief Operating Officer

Officer
6,048 -2.3%
8.33
US$50,380 		6,048 -2.3% 8.33 US$50,380
2023-01-31 2023-01-30 PlS Planned sale
Becker Marc A.

Chief Financial Officer

Officer
8,493 -6.2%
8.35
US$70,917 		8,493 -6.2% 8.35 US$70,917
2023-01-31 2023-01-30 PlS Planned sale
Cassella James V

Chief Development Officer

Officer
10,106 -5.4%
8.35
US$84,385 		10,106 -5.4% 8.35 US$84,385
2023-01-31 2023-01-30 PlS Planned sale
2.4
Stuart Nancy

Chief Operating Officer

Officer
13,200 -4.7%
8.35
US$110,220 		13,200 -4.7% 8.35 US$110,220
2023-01-31 2023-01-30 PlS Planned sale
Munsie Jeffrey A

Chief Legal Officer

Officer
8,493 -8.5%
8.35
US$70,917 		8,493 -8.5% 8.35 US$70,917
2023-01-09 2023-01-06 PlS Planned sale
2.4
Stuart Nancy

Chief Operating Officer

Officer
2,893 -1.0%
7.25
US$20,974 		2,893 -1.0% 7.25 US$20,974
2023-01-09 2023-01-06 PlS Planned sale
Tung Roger D

Chief Executive Officer

Executive Director
9,240 -0.9%
7.24
US$66,898 		9,240 -0.9% 7.24 US$66,898
2023-01-09 2023-01-06 PlS Planned sale
Cassella James V

Chief Development Officer

Officer
2,893 -1.5%
7.25
US$20,974 		2,893 -1.5% 7.25 US$20,974
2023-01-09 2023-01-06 PlS Planned sale
Munsie Jeffrey A

Chief Legal Officer

Officer
2,893 -2.8%
7.25
US$20,974 		2,893 -2.8% 7.25 US$20,974
2023-01-09 2023-01-06 PlS Planned sale
Becker Marc A.

Chief Financial Officer

Officer
2,893 -2.1%
7.25
US$20,974 		2,893 -2.1% 7.25 US$20,974
2022-10-18 2022-10-14 S Sale
2.3
HUTT PETER BARTON
Non-Executive Director
3,539 -10.7%
6.09
US$21,553 		3,539 -10.7% 6.09 US$21,553
2022-06-06 2022-06-06 B Purchase
3.0
Auchincloss Thomas G
Non-Executive Director
6,000 +51.6%
4.75
US$28,500 		6,000 +51.6% 4.75 US$28,500
2022-06-06 2022-06-06 B Purchase
2.4
ALDRICH RICHARD
Non-Executive Director
210,526 +inf%
4.75
US$999,998 		210,526 +inf% 4.75 US$999,998
2022-06-06 2022-06-06 B Purchase
3.1
van Heek Christi
Non-Executive Director
10,526 +69.6%
4.75
US$49,998 		10,526 +69.6% 4.75 US$49,998
2022-02-16 2022-02-15 PlS Planned sale
Tung Roger D

Chief Executive Officer

Executive Director
13,480 -1.4%
3.09
US$41,653 		13,480 -1.4% 3.09 US$41,653
2022-02-16 2022-02-14 PlS Planned sale
2.4
Stuart Nancy

Chief Operating Officer

Officer
6,049 -2.1%
3.08
US$18,631 		6,049 -2.1% 3.08 US$18,631
2022-02-16 2022-02-14 PlS Planned sale
Becker Marc A.

Chief Financial Officer

Officer
3,762 -2.6%
3.08
US$11,587 		3,762 -2.6% 3.08 US$11,587
2022-02-16 2022-02-14 PlS Planned sale
Munsie Jeffrey A

Chief Legal Officer

Officer
3,762 -3.5%
3.09
US$11,625 		3,762 -3.5% 3.09 US$11,625
2022-02-16 2022-02-14 PlS Planned sale
Cassella James V

Chief Development Officer

Officer
3,762 -1.9%
3.09
US$11,625 		3,762 -1.9% 3.09 US$11,625
2022-01-07 2022-01-06 PlS Planned sale
Tung Roger D

Chief Executive Officer

Executive Director
9,240 -1.2%
3.09
US$28,552 		9,240 -1.2% 3.09 US$28,552
2022-01-07 2022-01-05 PlS Planned sale
Becker Marc A.

Chief Financial Officer

Officer
2,894 -4.5%
3.20
US$9,261 		2,894 -4.5% 3.20 US$9,261
2022-01-07 2022-01-05 PlS Planned sale
2.4
Stuart Nancy

Chief Operating Officer

Officer
2,894 -1.7%
3.19
US$9,232 		2,894 -1.7% 3.19 US$9,232
2022-01-07 2022-01-05 PlS Planned sale
Cassella James V

Chief Development Officer

Officer
2,894 -3.4%
3.19
US$9,232 		2,894 -3.4% 3.19 US$9,232
2022-01-07 2022-01-05 PlS Planned sale
Munsie Jeffrey A

Chief Legal Officer

Officer
2,894 -6.3%
3.20
US$9,261 		2,894 -6.3% 3.20 US$9,261
2021-12-15 2021-12-13 PlS Planned sale
Tung Roger D

Chief Executive Officer

Executive Director
6,700 -0.8%
3.62
US$24,254 		6,700 -0.8% 3.62 US$24,254
2021-02-17 2021-02-17 PlS Planned sale
Tung Roger D

Chief Executive Officer

Executive Director
13,480 -1.6%
7.20
US$97,056 		13,480 -1.6% 7.20 US$97,056
2021-02-17 2021-02-16 PlS Planned sale
Becker Marc A.

Chief Financial Officer

Officer
3,763 -5.0%
7.32
US$27,545 		3,763 -5.0% 7.32 US$27,545
2021-02-17 2021-02-16 PlS Planned sale
Munsie Jeffrey A

Chief Legal Officer

Officer
3,763 -7.5%
7.32
US$27,545 		3,763 -7.5% 7.32 US$27,545
2021-02-17 2021-02-16 PlS Planned sale
Cassella James V

Chief Development Officer

Officer
3,763 -3.8%
7.32
US$27,545 		3,763 -3.8% 7.32 US$27,545
2021-02-17 2021-02-16 PlS Planned sale
2.4
Stuart Nancy

Chief Operating Officer

Officer
6,049 -3.4%
7.32
US$44,279 		6,049 -3.4% 7.32 US$44,279
2020-08-19 2020-08-17 PlS Planned sale
Cassella James V

Chief Development Officer

Officer
4,354 -5.4%
10.37
US$45,151 		4,354 -5.4% 10.37 US$45,151
2020-08-19 2020-08-17 PlS Planned sale
Becker Marc A.

Chief Financial Officer

Officer
2,875 -5.1%
10.24
US$29,440 		2,875 -5.1% 10.24 US$29,440
2020-06-24 2020-06-22 S Sale
2.4
Stuart Nancy

Chief Operating Officer

Officer
10,295 -6.1%
11.34
US$116,694 		10,295 -6.1% 11.34 US$116,694
2020-03-13 2020-03-12 B Purchase
3.0
Auchincloss Thomas G
Non-Executive Director
1,500 +30.0%
8.52
US$12,772 		1,500 +30.0% 8.52 US$12,772
2020-02-04 2020-02-03 B Purchase
3.0
Auchincloss Thomas G
1,000 +25.0%
10.91
US$10,910 		1,000 +25.0% 10.91 US$10,910
2019-10-10 2019-10-08 B Purchase
3.1
van Heek Christi
5,000 +100.0%
5.90
US$29,504 		5,000 +100.0% 5.90 US$29,504
2019-08-12 2019-08-08 S Sale HUTT PETER BARTON Non-Executive Director
3,539 -44.4%
10.31
US$36,487 		3,539 -44.4% 10.31 US$36,487
2019-10-10 2019-08-02 B Purchase
3.1
van Heek Christi
5,000 +inf%
10.84
US$54,203 		5,000 +inf% 10.84 US$54,203
2019-06-12 2019-06-10 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
29,450 -14.8%
10.70
US$315,230 		29,450 -14.8% 10.70 US$315,230
2019-06-12 2019-06-10 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
158,583 -14.3%
10.70
US$1,697,457 		158,583 -14.3% 10.70 US$1,697,457
2019-06-12 2019-06-10 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
198,256 -14.4%
10.70
US$2,122,112 		198,256 -14.4% 10.70 US$2,122,112
2018-11-19 2018-11-15 B Purchase Auchincloss Thomas G Non-Executive Director
1,000 +33.3%
11.50
US$11,500 		1,000 +33.3% 11.50 US$11,500
2018-11-15 2018-11-15 B Purchase ALDRICH RICHARD Non-Executive Director
40,000 +13.5%
11.78
US$471,268 		40,000 +13.5% 11.78 US$471,268
2018-11-15 2018-11-15 B Purchase ALDRICH RICHARD Non-Executive Director
10,000 +3.5%
12.00
US$119,994 		10,000 +3.5% 12.00 US$119,994
2018-11-15 2018-11-14 B Purchase Auchincloss Thomas G Non-Executive Director
1,000 +50.0%
11.93
US$11,931 		1,000 +50.0% 11.93 US$11,931
2018-07-11 2018-07-10 PlS Planned sale Stuart Nancy

Chief Operating Officer

Officer
26,127 -22.5%
17.94
US$468,697 		26,127 -22.5% 17.94 US$468,697
2018-07-11 2018-07-09 PlS Planned sale Stuart Nancy

Chief Operating Officer

Officer
5,291 -4.4%
17.56
US$92,890 		5,291 -4.4% 17.56 US$92,890
2018-04-19 2018-04-17 PlS Planned sale Cassella James V

Chief Development Officer

Officer
10,582 -26.1%
20.18
US$213,510 		10,582 -26.1% 20.18 US$213,510
2018-02-01 2018-02-01 PlS Planned sale ALDRICH RICHARD Non-Executive Director
1,946 -100.0%
19.99
US$38,901 		1,946 -100.0% 19.99 US$38,901
2018-02-01 2018-01-31 PlS Planned sale ALDRICH RICHARD Non-Executive Director
300 -13.4%
21.29
US$6,387 		300 -13.4% 21.29 US$6,387
2018-02-01 2018-01-31 PlS Planned sale ALDRICH RICHARD Non-Executive Director
4,700 -67.7%
20.78
US$97,666 		4,700 -67.7% 20.78 US$97,666
2018-02-01 2018-01-30 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -41.9%
21.33
US$106,650 		5,000 -41.9% 21.33 US$106,650
2018-01-29 2018-01-29 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -29.5%
21.36
US$106,800 		5,000 -29.5% 21.36 US$106,800
2018-01-29 2018-01-26 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -22.8%
20.46
US$102,300 		5,000 -22.8% 20.46 US$102,300
2018-01-29 2018-01-25 PlS Planned sale ALDRICH RICHARD Non-Executive Director
3,054 -6.4%
20.22
US$61,752 		3,054 -6.4% 20.22 US$61,752
2018-01-29 2018-01-25 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -18.6%
20.31
US$101,550 		5,000 -18.6% 20.31 US$101,550
2018-01-24 2018-01-24 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -9.5%
19.83
US$99,150 		5,000 -9.5% 19.83 US$99,150
2018-01-24 2018-01-24 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -15.7%
19.83
US$99,150 		5,000 -15.7% 19.83 US$99,150
2018-01-24 2018-01-23 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -8.7%
19.68
US$98,400 		5,000 -8.7% 19.68 US$98,400
2018-01-24 2018-01-23 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -13.5%
19.67
US$98,350 		5,000 -13.5% 19.67 US$98,350
2018-01-24 2018-01-22 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -8.0%
19.54
US$97,700 		5,000 -8.0% 19.54 US$97,700
2018-01-24 2018-01-22 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -11.9%
19.55
US$97,750 		5,000 -11.9% 19.55 US$97,750
2018-01-19 2018-01-19 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -7.4%
19.65
US$98,250 		5,000 -7.4% 19.65 US$98,250
2018-01-19 2018-01-19 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -10.7%
19.66
US$98,300 		5,000 -10.7% 19.66 US$98,300
2018-01-19 2018-01-18 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -6.9%
19.43
US$97,150 		5,000 -6.9% 19.43 US$97,150
2018-01-19 2018-01-18 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -9.6%
19.36
US$96,800 		5,000 -9.6% 19.36 US$96,800
2018-01-19 2018-01-17 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -6.5%
19.03
US$95,150 		5,000 -6.5% 19.03 US$95,150
2018-01-19 2018-01-17 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -8.8%
18.95
US$94,750 		5,000 -8.8% 18.95 US$94,750
2018-01-18 2018-01-16 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -6.1%
19.26
US$96,300 		5,000 -6.1% 19.26 US$96,300
2018-01-18 2018-01-16 PlS Planned sale ALDRICH RICHARD Non-Executive Director
5,000 -8.1%
19.27
US$96,350 		5,000 -8.1% 19.27 US$96,350
2018-01-18 2018-01-16 PlS Planned sale ALDRICH RICHARD Non-Executive Director
21,236 -6.9%
19.08
US$405,183 		21,236 -6.9% 19.08 US$405,183
2017-12-21 2017-12-19 S Sale BVF PARTNERS L P/IL Large shareholder
169,292 -58.0%
26.65
US$4,511,632 		169,292 -58.0% 26.65 US$4,511,632
Explore more

More insider trading research around Concert Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America